• Explore /
  • Poster
  • / The Bristol Bladder trial: A single-arm phase II trial of cisplatin and cabazitaxel for muscle invasive transitional cell carcinoma of the urinary bladder prior to radical cystectomy.

The Bristol Bladder trial: A single-arm phase II trial of cisplatin and cabazitaxel for muscle invasive transitional cell carcinoma of the urinary bladder prior to radical cystectomy.

Abstract Poster

Authors

null

Amit Bahl

Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom

Amit Bahl , Susan Masson , Amarnath Challapalli , Alicia Bravo , Sylvia Pearson , Serena Hilman , Raj Persad , Anthony Koupparis , Edward Rowe , Emily Foulstone , Heidi Evans , Jon Oxley , Rosemary Greenwood , Hannah Kirk , Rebecca Huckett , Julian Kabala , Janice Ash-Miles , Narges Dailami , Claire Perks , Jeff Holly

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT01616875

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr 468)

DOI

10.1200/JCO.2018.36.6_suppl.468

Abstract #

468

Poster Bd #

H17

Abstract Disclosures

Similar Posters

First Author: Amarnath Challapalli

First Author: Richard Cathomas

First Author: Xiao Yang

First Author: Dorte Nielsen